SEC Form 4 · accession 0000899243-16-032070
CRISPR Therapeutics AG · CRSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pablo J Cagnoni
Director
Period of report
Oct 18, 2016
Accepted (ET)
Oct 20, 2016 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674416
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $14.00 | Oct 18, 2016 | A | 15,000 | A | — | Oct 18, 2026 | Common Shares | 15,000 | 15,000 | D |
Explanation of responses
- F1This option was granted on October 18, 2016 with respect to 15,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning October 31, 2016.